ERBB2 and breast cancer: However, in 20–25% of BCs, known as HER2-positive BCs, the cancer cells express greater numbers of HER2 receptors [3] and HER2-positive breast cancers tend to grow more quickly and are more likely to recur and metastasise than HER2-negative breast cancers [3].